{
    "2021-02-27": [
        [
            {
                "time": "2021-02-27",
                "original_text": "FDA authorizes the first single-dose COVID-19 vaccine",
                "features": {
                    "keywords": [
                        "FDA",
                        "authorizes",
                        "single-dose",
                        "COVID-19",
                        "vaccine"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-02-27",
                "original_text": "UPDATE 3-U.S. authorizes J&J's COVID-19 vaccine, making it third available",
                "features": {
                    "keywords": [
                        "U.S.",
                        "authorizes",
                        "J&J",
                        "COVID-19",
                        "vaccine",
                        "third"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-02-27",
                "original_text": "EXPLAINER-What J&J's authorized COVID-19 shot means for the U.S. vaccination campaign",
                "features": {
                    "keywords": [
                        "J&J",
                        "authorized",
                        "COVID-19",
                        "shot",
                        "U.S.",
                        "vaccination",
                        "campaign"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-02-27",
                "original_text": "U.S. authorizes Johnson & Johnson's COVID-19 vaccine",
                "features": {
                    "keywords": [
                        "U.S.",
                        "authorizes",
                        "Johnson",
                        "&",
                        "Johnson",
                        "COVID-19",
                        "vaccine"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-02-27",
                "original_text": "Johnson & Johnson's COVID-19 Vaccine Is Cleared by the FDA",
                "features": {
                    "keywords": [
                        "Johnson",
                        "&",
                        "Johnson",
                        "COVID-19",
                        "Vaccine",
                        "Cleared",
                        "FDA"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-02-28",
                "original_text": "Got $1,000? 2 Stocks You Can Buy and Hold for Decades",
                "features": {
                    "keywords": [
                        "$1,000",
                        "Stocks",
                        "Buy",
                        "Hold",
                        "Decades"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-28",
                "original_text": "3 Green Flags for Johnson & Johnson's Future",
                "features": {
                    "keywords": [
                        "Green",
                        "Flags",
                        "Johnson",
                        "&",
                        "Johnson",
                        "Future"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-26",
                "original_text": "Johnson & Johnson's Vaccine Gets Unanimous Backing Of FDA Panel, Emergency-Use Authorization Soon To Come",
                "features": {
                    "keywords": [
                        "Johnson",
                        "&",
                        "Johnson",
                        "Vaccine",
                        "Unanimous",
                        "Backing",
                        "FDA",
                        "Panel",
                        "Emergency-Use",
                        "Authorization"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-02-28",
                "original_text": "The Pandemic Tested Healthcare R&D. Now the Future Looks Bright.",
                "features": {
                    "keywords": [
                        "Pandemic",
                        "Tested",
                        "Healthcare",
                        "R&D",
                        "Future",
                        "Bright"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-01",
                "original_text": "Johnson & Johnson’s vaccine rollout marred by production problems",
                "features": {
                    "keywords": [
                        "Johnson",
                        "&",
                        "Johnson",
                        "vaccine",
                        "rollout",
                        "marred",
                        "production",
                        "problems"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-02-27",
                "original_text": "FDA moves to authorize Johnson & Johnson’s Covid-19 vaccine",
                "features": {
                    "keywords": [
                        "FDA",
                        "moves",
                        "authorize",
                        "Johnson",
                        "&",
                        "Johnson",
                        "Covid-19",
                        "vaccine"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}